查看购物车
  • Traditional Chinese
  • English
封面
市场调查报告书
商品编码
1547943

全球护理点传染病检测市场研究报告 - 2024 年至 2032 年产业分析、规模、份额、成长、趋势与预测

Global Point of Care Infectious Disease Testing Market Research Report - Industry Analysis, Size, Share, Growth, Trends and Forecast 2024 to 2032
出版日期: | 出版商: Value Market Research | 英文 128 Pages | 商品交期: 最快1-2个工作天内

价格

全球即时传染病检测市场需求预计将从 2023 年的 401.2 亿美元增至 2032 年的近 810.1 亿美元，2024-2032 年研究期间复合年增长率为 8.12%。

护理点传染病检测是一种检测机制，用于在非常接近患者的环境中检测主要病原体，从而更好地管理传染病。它用于检测多种主要疾病，如爱滋病毒、HPV、结核病、登革热、伊波拉病毒、冠状病毒。这种测试有助于遏止传染病的快速爆发。它们通常用于资源有限的环境，及时获得优质医疗服务是一项挑战。 POCT 的一些例子包括侧流免疫测定 (LFIA) 和酵素免疫测定 (ELISA)。只有建立有效的检测结果报告和后续照护系统，POCT 才会对社会产生正面影响。

市场动态

全球传染病的高发生率以及病毒和流行病的快速爆发是POCT市场成长的主要驱动力。低成本便携式设备的可用性、农村和偏远地区的易用性、缺乏满足贫困人口需求的医疗基础设施将是推动该市场成长的主要因素。政府增加对这些测试方法的小型化和标准化的投资将是一个巨大的市场推动力。 COVID-19大流行期间ELISA试剂盒销量的增加导致POCT市场以惊人的速度成长。阻碍该市场的主要问题是低抗原水平样本缺乏临床敏感性以及假阴性结果的可能性增加。

研究报告涵盖波特五力模型、市场吸引力分析和价值链分析。这些工具有助于清晰地了解行业结构并评估全球范围内的竞争吸引力。此外，这些工具也对全球护理点传染病检测市场的各个细分市场进行了包容性评估。护理点传染病检测产业的成长和趋势为这项研究提供了整体方法。

市场区隔

护理点传染病检测市场报告的这一部分提供了国家和区域层面细分市场的详细资料，从而帮助策略师确定相应产品或服务的目标人口统计数据以及即将到来的机会。

按疾病分类

  • 爱滋病毒POC
  • 艰难梭菌POC
  • 乙肝病毒POC
  • 肺炎或链球菌相关感染
  • 呼吸道合胞病毒 (RSV) POC
  • HPV POC
  • 流感/流感 POC
  • 丙型肝炎病毒POC
  • 耐甲氧西林金黄色葡萄球菌POC
  • 结核病和抗药性结核病 POC
  • HSV（单纯疱疹病毒）POC
  • 其他传染病POC

按最终用途

  • 医院
  • 诊所
  • 家
  • 辅助生活医疗设施
  • 实验室
  • 其他的

区域分析

本节涵盖区域前景，重点介绍北美、欧洲、亚太地区、拉丁美洲以及中东和非洲即时传染病检测市场当前和未来的需求。此外，该报告重点关注所有主要地区各个应用领域的需求、估计和预测。

该研究报告还涵盖了市场主要参与者的全面概况以及对全球竞争格局的深入了解。即时传染病检测市场的主要参与者包括 Alere、Thermo Fisher Scientific Inc、F. Hoffmann-La Roche Ltd、Siemens Healthineers、BD & Company、Chembio Diagnostics Inc.、Trinity Biotech、Cardinal Health、Quest Diagnostics Inc.。 -Rad Labs Inc.、BioMeRieux SA、Sight Diagnostics Ltd.、Gene POC、Trivitron Healthcare、OJ-Bio Ltd.、Ortho-Clinical Diagnostics。本节包含竞争格局的整体视图，包括各种策略发展，例如关键併购、未来产能、合作伙伴关係、财务概况、合作、新产品开发、新产品发布和其他发展。

如果您有任何客製化要求，请写信给我们。我们的研究团队可以根据您的需求提供客製化报告。

目录

第一章：前言

  • 报告说明
    • 客观的
    • 目标受众
    • 独特的销售主张 (USP) 和产品
  • 研究范围
  • 研究方法
    • 市场研究过程
    • 市场研究方法论

第 2 章：执行摘要

  • 市集亮点
  • 全球市场概况

第 3 章：护理点传染病检测 - 产业分析

  • 简介 - 市场动态
  • 市场驱动因素
  • 市场限制
  • 机会
  • 产业动态
  • 波特五力分析
  • 市场吸引力分析
    • 按疾病分类的市场吸引力分析
    • 按最终用途分類的市场吸引力分析
    • 市场吸引力分析：按地区

第 4 章：价值链分析

  • 价值链分析
  • 原料分析
    • 原料清单
    • 原料厂商清单
    • 主要原物料价格走势
  • 潜在买家名单
  • 行销管道
    • 直效行销
    • 间接行销
    • 行销通路发展趋势

第 5 章：全球护理点传染病检测市场分析：依疾病分类

  • 按疾病分类概述
  • 历史和预测数据
  • 按疾病分析
  • 爱滋病毒POC
  • 艰难梭菌POC
  • 乙肝病毒POC
  • 肺炎或链球菌相关感染
  • 呼吸道合胞病毒 (RSV) POC
  • HPV POC
  • 流感/流感 POC
  • 丙型肝炎病毒POC
  • 耐甲氧西林金黄色葡萄球菌POC
  • 结核病和抗药性结核病 POC
  • HSV（单纯疱疹病毒）POC
  • 其他传染病POC

第 6 章：全球护理点传染病检测市场分析：依最终用途分类

  • 按最终用途分类的概述
  • 历史和预测数据
  • 按最终用途分析
  • 医院
  • 诊所
  • 家
  • 辅助生活医疗设施
  • 实验室
  • 其他的

第 7 章：全球护理点传染病检测市场分析：依地理位置

  • 区域展望
  • 介绍
  • 北美销售分析
    • 概览、历史与预测资料销售分析
    • 北美按细分市场销售分析
    • 北美按国家销售分析
    • 美国销售分析
    • 加拿大销售分析
    • 墨西哥销售分析
  • 欧洲销售分析
    • 概览、历史与预测资料销售分析
    • 欧洲按细分市场销售分析
    • 欧洲按国家销售分析
    • 英国销售分析
    • 法国销售分析
    • 德国销售分析
    • 义大利销售分析
    • 俄罗斯销售分析
    • 欧洲其他地区销售分析
  • 亚太地区销售分析
    • 概览、历史与预测资料销售分析
    • 亚太地区按细分市场销售分析
    • 亚太地区按国家销售分析
    • 中国销售分析
    • 印度销售分析
    • 日本销售分析
    • 韩国销售分析
    • 澳洲销售分析
    • 东南亚销售分析
    • 亚太地区其他地区销售分析
  • 拉丁美洲销售分析
    • 概览、历史与预测资料销售分析
    • 拉丁美洲按细分市场销售分析
    • 拉丁美洲按国家销售分析
    • 巴西销售分析
    • 阿根廷销售分析
    • 秘鲁销售分析
    • 智利销售分析
    • 拉丁美洲其他地区销售分析
  • 中东和非洲销售分析
    • 概览、历史与预测资料销售分析
    • 中东和非洲按细分市场销售分析
    • 中东和非洲按国家销售分析
    • 沙乌地阿拉伯销售分析
    • 阿联酋销售分析
    • 以色列销售分析
    • 南非销售分析
    • 中东其他地区和非洲销售分析

第 8 章：护理点传染病检测公司的竞争格局

  • 护理点传染病检测市场竞争
  • 伙伴关係/协作/协议
  • 併购
  • 新产品发布
  • 其他发展

第 9 章：公司简介

  • 顶级公司市占率分析
  • 市场集中度
  • Alere
    • 公司概况
    • 公司收入
    • 产品
    • 最新动态
  • Thermo Fisher Scientific Inc
    • 公司概况
    • 公司收入
    • 产品
    • 最新动态
  • F. Hoffmann-La Roche Ltd
    • 公司概况
    • 公司收入
    • 产品
    • 最新动态
  • Siemens Healthineers
    • 公司概况
    • 公司收入
    • 产品
    • 最新动态
  • BD & Company
    • 公司概况
    • 公司收入
    • 产品
    • 最新动态
  • Chembio Diagnostics Inc.
    • 公司概况
    • 公司收入
    • 产品
    • 最新动态
  • Trinity Biotech
    • 公司概况
    • 公司收入
    • 产品
    • 最新动态
  • Cardinal Health
    • 公司概况
    • 公司收入
    • 产品
    • 最新动态
  • Quest Diagnostics Inc.
    • 公司概况
    • 公司收入
    • 产品
    • 最新动态
  • Bio-Rad Labs Inc.
    • 公司概况
    • 公司收入
    • 产品
    • 最新动态
  • BioMeRieux SA
    • 公司概况
    • 公司收入
    • 产品
    • 最新动态
  • Sight Diagnostics Ltd.
    • 公司概况
    • 公司收入
    • 产品
    • 最新动态
  • Gene POC
    • 公司概况
    • 公司收入
    • 产品
    • 最新动态
  • Trivitron Healthcare
    • 公司概况
    • 公司收入
    • 产品
    • 最新动态
  • OJ-Bio Ltd.
    • 公司概况
    • 公司收入
    • 产品
    • 最新动态
  • Ortho-Clinical Diagnostics
    • 公司概况
    • 公司收入
    • 产品
    • 最新动态

註 - 在公司概况中，财务详细资讯和最新发展视情况而定，或对私人公司而言可能不包括在内

Product Code: VMR11212341

The global demand for Point of Care Infectious Disease Testing Market is presumed to reach the market size of nearly USD 81.01 Billion by 2032 from USD 40.12 Billion in 2023 with a CAGR of 8.12% under the study period 2024-2032.

Point of Care Infectious Disease Testing is a testing mechanism used to test major pathogens in an environment setting very close to the patient and enable better management of infectious diseases. It is used to test several major diseases like HIV, HPV, TB, dengue, Ebola, Coronaviruses. This testing can help in the containment of rapid outbreaks of infectious diseases. They are commonly used in resource-limited settings where access to quality medical care in a timely manner is a challenge. Some examples of POCT are lateral flow immunoassays (LFIA) and enzyme immunoassay (ELISA). POCT will have a positive impact on society only if effective systems for reporting test results and follow up care are in place.

MARKET DYNAMICS

The high prevalence of infectious diseases and rapid outbreaks of viruses and epidemics globally are the main drivers for the growth of the POCT market. Availability of low-cost portable devices, ease of use in rural and remote areas, lack of healthcare infrastructure to meet the demands of the distressed will be major factors that will boost the growth of this market. Increased investments from governments for miniaturization and standardization of these testing methods will be a great market booster. Increase in the sales of ELISA kits during the COVID-19 pandemic led to the growth of the POCT market at an alarming rate. The major concerns hampering this market are lack of clinical sensitivity for specimens with low antigen levels and increased possibility of false-negative results.

The research report covers Porter's Five Forces Model, Market Attractiveness Analysis, and Value Chain analysis. These tools help to get a clear picture of the industry's structure and evaluate the competition attractiveness at a global level. Additionally, these tools also give an inclusive assessment of each segment in the global market of Point of Care Infectious Disease Testing. The growth and trends of Point of Care Infectious Disease Testing industry provide a holistic approach to this study.

MARKET SEGMENTATION

This section of the Point of Care Infectious Disease Testing market report provides detailed data on the segments at country and regional level, thereby assisting the strategist in identifying the target demographics for the respective product or services with the upcoming opportunities.

By Disease

  • HIV POC
  • Clostridium difficile POC
  • HBV POC
  • Pneumonia or Streptococcus associated infections
  • Respiratory syncytial virus (RSV) POC
  • HPV POC
  • Influenza/Flu POC
  • HCV POC
  • MRSA POC
  • TB and drug-resistant TB POC
  • HSV (Herpes Simplex Virus) POC
  • Other infectious disease POC

By End-Use

  • Hospitals
  • Clinics
  • Home
  • Assisted Living Healthcare Facilities
  • Laboratories
  • Others

REGIONAL ANALYSIS

This section covers the regional outlook, which accentuates current and future demand for the Point of Care Infectious Disease Testing market across North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa. Further, the report focuses on demand, estimation, and forecast for individual application segments across all the prominent regions.

The research report also covers the comprehensive profiles of the key players in the market and an in-depth view of the competitive landscape worldwide. The major players in the Point of Care Infectious Disease Testing market include Alere, Thermo Fisher Scientific Inc, F. Hoffmann-La Roche Ltd, Siemens Healthineers, BD & Company, Chembio Diagnostics Inc., Trinity Biotech, Cardinal Health, Quest Diagnostics Inc., Bio-Rad Labs Inc., BioMeRieux SA, Sight Diagnostics Ltd., Gene POC, Trivitron Healthcare, OJ-Bio Ltd., Ortho-Clinical Diagnostics. This section consists of a holistic view of the competitive landscape that includes various strategic developments such as key mergers & acquisitions, future capacities, partnerships, financial overviews, collaborations, new product developments, new product launches, and other developments.

In case you have any custom requirements, do write to us. Our research team can offer a customized report as per your need.

TABLE OF CONTENTS

1. PREFACE

  • 1.1. Report Description
    • 1.1.1 Objective
    • 1.1.2 Target Audience
    • 1.1.3 Unique Selling Proposition (USP) & offerings
  • 1.2. Research Scope
  • 1.3. Research Methodology
    • 1.3.1 Market Research Process
    • 1.3.2 Market Research Methodology

2. EXECUTIVE SUMMARY

  • 2.1. Highlights of Market
  • 2.2. Global Market Snapshot

3. POINT OF CARE INFECTIOUS DISEASE TESTING - INDUSTRY ANALYSIS

  • 3.1. Introduction - Market Dynamics
  • 3.2. Market Drivers
  • 3.3. Market Restraints
  • 3.4. Opportunities
  • 3.5. Industry Trends
  • 3.6. Porter's Five Force Analysis
  • 3.7. Market Attractiveness Analysis
    • 3.7.1 Market Attractiveness Analysis By Disease
    • 3.7.2 Market Attractiveness Analysis By End-Use
    • 3.7.3 Market Attractiveness Analysis By Region

4. VALUE CHAIN ANALYSIS

  • 4.1. Value Chain Analysis
  • 4.2. Raw Material Analysis
    • 4.2.1 List of Raw Materials
    • 4.2.2 Raw Material Manufactures List
    • 4.2.3 Price Trend of Key Raw Materials
  • 4.3. List of Potential Buyers
  • 4.4. Marketing Channel
    • 4.4.1 Direct Marketing
    • 4.4.2 Indirect Marketing
    • 4.4.3 Marketing Channel Development Trend

5. GLOBAL POINT OF CARE INFECTIOUS DISEASE TESTING MARKET ANALYSIS BY DISEASE

  • 5.1. Overview By Disease
  • 5.2. Historical and Forecast Data
  • 5.3. Analysis By Disease
  • 5.4. HIV POC Historic and Forecast Sales By Regions
  • 5.5. Clostridium difficile POC Historic and Forecast Sales By Regions
  • 5.6. HBV POC Historic and Forecast Sales By Regions
  • 5.7. Pneumonia or Streptococcus associated infections Historic and Forecast Sales By Regions
  • 5.8. Respiratory syncytial virus (RSV) POC Historic and Forecast Sales By Regions
  • 5.9. HPV POC Historic and Forecast Sales By Regions
  • 5.10. Influenza/Flu POC Historic and Forecast Sales By Regions
  • 5.11. HCV POC Historic and Forecast Sales By Regions
  • 5.12. MRSA POC Historic and Forecast Sales By Regions
  • 5.13. TB and drug-resistant TB POC Historic and Forecast Sales By Regions
  • 5.14. HSV (Herpes Simplex Virus) POC Historic and Forecast Sales By Regions
  • 5.15. Other infectious disease POC Historic and Forecast Sales By Regions

6. GLOBAL POINT OF CARE INFECTIOUS DISEASE TESTING MARKET ANALYSIS BY END-USE

  • 6.1. Overview By End-Use
  • 6.2. Historical and Forecast Data
  • 6.3. Analysis By End-Use
  • 6.4. Hospitals Historic and Forecast Sales By Regions
  • 6.5. Clinics Historic and Forecast Sales By Regions
  • 6.6. Home Historic and Forecast Sales By Regions
  • 6.7. Assisted Living Healthcare Facilities Historic and Forecast Sales By Regions
  • 6.8. Laboratories Historic and Forecast Sales By Regions
  • 6.9. Others Historic and Forecast Sales By Regions

7. GLOBAL POINT OF CARE INFECTIOUS DISEASE TESTING MARKET ANALYSIS BY GEOGRAPHY

  • 7.1. Regional Outlook
  • 7.2. Introduction
  • 7.3. North America Sales Analysis
    • 7.3.1 Overview, Historic and Forecast Data Sales Analysis
    • 7.3.2 North America By Segment Sales Analysis
    • 7.3.3 North America By Country Sales Analysis
    • 7.3.4 United States Sales Analysis
    • 7.3.5 Canada Sales Analysis
    • 7.3.6 Mexico Sales Analysis
  • 7.4. Europe Sales Analysis
    • 7.4.1 Overview, Historic and Forecast Data Sales Analysis
    • 7.4.2 Europe By Segment Sales Analysis
    • 7.4.3 Europe By Country Sales Analysis
    • 7.4.4 United Kingdom Sales Analysis
    • 7.4.5 France Sales Analysis
    • 7.4.6 Germany Sales Analysis
    • 7.4.7 Italy Sales Analysis
    • 7.4.8 Russia Sales Analysis
    • 7.4.9 Rest Of Europe Sales Analysis
  • 7.5. Asia Pacific Sales Analysis
    • 7.5.1 Overview, Historic and Forecast Data Sales Analysis
    • 7.5.2 Asia Pacific By Segment Sales Analysis
    • 7.5.3 Asia Pacific By Country Sales Analysis
    • 7.5.4 China Sales Analysis
    • 7.5.5 India Sales Analysis
    • 7.5.6 Japan Sales Analysis
    • 7.5.7 South Korea Sales Analysis
    • 7.5.8 Australia Sales Analysis
    • 7.5.9 South East Asia Sales Analysis
    • 7.5.10 Rest Of Asia Pacific Sales Analysis
  • 7.6. Latin America Sales Analysis
    • 7.6.1 Overview, Historic and Forecast Data Sales Analysis
    • 7.6.2 Latin America By Segment Sales Analysis
    • 7.6.3 Latin America By Country Sales Analysis
    • 7.6.4 Brazil Sales Analysis
    • 7.6.5 Argentina Sales Analysis
    • 7.6.6 Peru Sales Analysis
    • 7.6.7 Chile Sales Analysis
    • 7.6.8 Rest of Latin America Sales Analysis
  • 7.7. Middle East & Africa Sales Analysis
    • 7.7.1 Overview, Historic and Forecast Data Sales Analysis
    • 7.7.2 Middle East & Africa By Segment Sales Analysis
    • 7.7.3 Middle East & Africa By Country Sales Analysis
    • 7.7.4 Saudi Arabia Sales Analysis
    • 7.7.5 UAE Sales Analysis
    • 7.7.6 Israel Sales Analysis
    • 7.7.7 South Africa Sales Analysis
    • 7.7.8 Rest Of Middle East And Africa Sales Analysis

8. COMPETITIVE LANDSCAPE OF THE POINT OF CARE INFECTIOUS DISEASE TESTING COMPANIES

  • 8.1. Point of Care Infectious Disease Testing Market Competition
  • 8.2. Partnership/Collaboration/Agreement
  • 8.3. Merger And Acquisitions
  • 8.4. New Product Launch
  • 8.5. Other Developments

9. COMPANY PROFILES OF POINT OF CARE INFECTIOUS DISEASE TESTING INDUSTRY

  • 9.1. Top Companies Market Share Analysis
  • 9.2. Market Concentration Rate
  • 9.3. Alere
    • 9.3.1 Company Overview
    • 9.3.2 Company Revenue
    • 9.3.3 Products
    • 9.3.4 Recent Developments
  • 9.4. Thermo Fisher Scientific Inc
    • 9.4.1 Company Overview
    • 9.4.2 Company Revenue
    • 9.4.3 Products
    • 9.4.4 Recent Developments
  • 9.5. F. Hoffmann-La Roche Ltd
    • 9.5.1 Company Overview
    • 9.5.2 Company Revenue
    • 9.5.3 Products
    • 9.5.4 Recent Developments
  • 9.6. Siemens Healthineers
    • 9.6.1 Company Overview
    • 9.6.2 Company Revenue
    • 9.6.3 Products
    • 9.6.4 Recent Developments
  • 9.7. BD & Company
    • 9.7.1 Company Overview
    • 9.7.2 Company Revenue
    • 9.7.3 Products
    • 9.7.4 Recent Developments
  • 9.8. Chembio Diagnostics Inc.
    • 9.8.1 Company Overview
    • 9.8.2 Company Revenue
    • 9.8.3 Products
    • 9.8.4 Recent Developments
  • 9.9. Trinity Biotech
    • 9.9.1 Company Overview
    • 9.9.2 Company Revenue
    • 9.9.3 Products
    • 9.9.4 Recent Developments
  • 9.10. Cardinal Health
    • 9.10.1 Company Overview
    • 9.10.2 Company Revenue
    • 9.10.3 Products
    • 9.10.4 Recent Developments
  • 9.11. Quest Diagnostics Inc.
    • 9.11.1 Company Overview
    • 9.11.2 Company Revenue
    • 9.11.3 Products
    • 9.11.4 Recent Developments
  • 9.12. Bio-Rad Labs Inc.
    • 9.12.1 Company Overview
    • 9.12.2 Company Revenue
    • 9.12.3 Products
    • 9.12.4 Recent Developments
  • 9.13. BioMeRieux SA
    • 9.13.1 Company Overview
    • 9.13.2 Company Revenue
    • 9.13.3 Products
    • 9.13.4 Recent Developments
  • 9.14. Sight Diagnostics Ltd.
    • 9.14.1 Company Overview
    • 9.14.2 Company Revenue
    • 9.14.3 Products
    • 9.14.4 Recent Developments
  • 9.15. Gene POC
    • 9.15.1 Company Overview
    • 9.15.2 Company Revenue
    • 9.15.3 Products
    • 9.15.4 Recent Developments
  • 9.16. Trivitron Healthcare
    • 9.16.1 Company Overview
    • 9.16.2 Company Revenue
    • 9.16.3 Products
    • 9.16.4 Recent Developments
  • 9.17. OJ-Bio Ltd.
    • 9.17.1 Company Overview
    • 9.17.2 Company Revenue
    • 9.17.3 Products
    • 9.17.4 Recent Developments
  • 9.18. Ortho-Clinical Diagnostics
    • 9.18.1 Company Overview
    • 9.18.2 Company Revenue
    • 9.18.3 Products
    • 9.18.4 Recent Developments

Note - In company profiling, financial details and recent developments are subject to availability or might not be covered in the case of private companies

LIST OF TABLES

  • Market Snapshot
  • Drivers: Impact Analysis
  • Restraints: Impact Analysis
  • List of Raw Material
  • List of Raw Material Manufactures
  • Analysis By Disease (USD MN)
  • HIV POC Market Sales By Geography (USD MN)
  • Clostridium difficile POC Market Sales By Geography (USD MN)
  • HBV POC Market Sales By Geography (USD MN)
  • Pneumonia or Streptococcus associated infections Market Sales By Geography (USD MN)
  • Respiratory syncytial virus (RSV) POC Market Sales By Geography (USD MN)
  • HPV POC Market Sales By Geography (USD MN)
  • Influenza/Flu POC Market Sales By Geography (USD MN)
  • HCV POC Market Sales By Geography (USD MN)
  • MRSA POC Market Sales By Geography (USD MN)
  • TB and drug-resistant TB POC Market Sales By Geography (USD MN)
  • HSV (Herpes Simplex Virus) POC Market Sales By Geography (USD MN)
  • Other infectious disease POC Market Sales By Geography (USD MN)
  • Analysis By End-Use (USD MN)
  • Hospitals Market Sales By Geography (USD MN)
  • Clinics Market Sales By Geography (USD MN)
  • Home Market Sales By Geography (USD MN)
  • Assisted Living Healthcare Facilities Market Sales By Geography (USD MN)
  • Laboratories Market Sales By Geography (USD MN)
  • Others Market Sales By Geography (USD MN)
  • Global Point of Care Infectious Disease Testing Market Sales By Geography (USD MN)
  • North America Market Analysis (USD MN)
  • United States Market Analysis (USD MN)
  • Canada Market Analysis (USD MN)
  • Mexico Market Analysis (USD MN)
  • Europe Market Analysis (USD MN)
  • Europe Market Estimate By Country (USD MN)
  • United Kingdom Market Analysis (USD MN)
  • France Market Analysis (USD MN)
  • Germany Market Analysis (USD MN)
  • Italy Market Analysis (USD MN)
  • Russia Market Analysis (USD MN)
  • Spain Market Analysis (USD MN)
  • Rest of Europe Market Analysis (USD MN)
  • Asia Pacific Market Analysis (USD MN)
  • China Market Analysis (USD MN)
  • Japan Market Analysis (USD MN)
  • India Market Analysis (USD MN)
  • South Korea Market Analysis (USD MN)
  • Australia Market Analysis (USD MN)
  • South East Asia Market Analysis (USD MN)
  • Rest of Asia Pacific Market Analysis (USD MN)
  • Latin America Market Analysis (USD MN)
  • Brazil Market Analysis (USD MN)
  • Argentina Market Analysis (USD MN)
  • Peru Market Analysis (USD MN)
  • Chile Market Analysis (USD MN)
  • Rest of Latin America Market Analysis (USD MN)
  • Middle East & Africa Market Analysis (USD MN)
  • Saudi Arabia Market Analysis (USD MN)
  • UAE Market Analysis (USD MN)
  • Israel Market Analysis (USD MN)
  • South Africa Market Analysis (USD MN)
  • Rest of Middle East and Africa Market Analysis (USD MN)
  • Partnership/Collaboration/Agreement
  • Mergers And Acquisition

LIST OF FIGURES

  • Research Scope of Point of Care Infectious Disease Testing Report
  • Market Research Process
  • Market Research Methodology
  • Global Point of Care Infectious Disease Testing Market Size, By Region (USD MN)
  • Porters Five Forces Analysis
  • Market Attractiveness Analysis By Disease
  • Market Attractiveness Analysis By End-Use
  • Market Attractiveness Analysis By Region
  • Value Chain Analysis
  • Global Market Analysis By Disease (USD MN)
  • HIV POC Market Sales By Geography (USD MN)
  • Clostridium difficile POC Market Sales By Geography (USD MN)
  • HBV POC Market Sales By Geography (USD MN)
  • Pneumonia or Streptococcus associated infections Market Sales By Geography (USD MN)
  • Respiratory syncytial virus (RSV) POC Market Sales By Geography (USD MN)
  • HPV POC Market Sales By Geography (USD MN)
  • Influenza/Flu POC Market Sales By Geography (USD MN)
  • HCV POC Market Sales By Geography (USD MN)
  • MRSA POC Market Sales By Geography (USD MN)
  • TB and drug-resistant TB POC Market Sales By Geography (USD MN)
  • HSV (Herpes Simplex Virus) POC Market Sales By Geography (USD MN)
  • Other infectious disease POC Market Sales By Geography (USD MN)
  • Global Market Analysis By End-Use (USD MN)
  • Hospitals Market Sales By Geography (USD MN)
  • Clinics Market Sales By Geography (USD MN)
  • Home Market Sales By Geography (USD MN)
  • Assisted Living Healthcare Facilities Market Sales By Geography (USD MN)
  • Laboratories Market Sales By Geography (USD MN)
  • Others Market Sales By Geography (USD MN)
  • Global Market Sales (USD MN)
  • North America Market Sales (USD MN)
  • Europe Market Sales (USD MN)
  • Asia Pacific Market Sales (USD MN)
  • Latin America Market Sales (USD MN)
  • Middle East & Africa Market Sales (USD MN)
  • Recent Development in Industry
  • Top Company Market Share Analysis

Kindly note that the above listed are the basic tables and figures of the report and are not limited to the TOC.